Aeolus Pharmaceuticals, Inc. Information

Aeolus Pharmaceuticals, Inc., a pharmaceutical company, engages in the development of medical countermeasures against biological, chemical, and radiological weapons in the United States. It also develops medical countermeasures for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology. The company primarily develops AEOL 10150, a phase I clinical trial lead product for various indications, such as a medical countermeasure against the effects of acute radiation syndrome in the lungs and gastro-intestinal tract, and as a medical countermeasure against the effects of chlorine gas. In addition, it has two programs for the development of AEOL 11207, a drug candidate for the potential treatment of epilepsy and Parkinson’s disease. The company was founded in 1994 and is based in Mission Viejo, California.